These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 36167736)
21. The effects of levosimendan in cardiac surgery patients with poor left ventricular function. De Hert SG; Lorsomradee S; Cromheecke S; Van der Linden PJ Anesth Analg; 2007 Apr; 104(4):766-73. PubMed ID: 17377079 [TBL] [Abstract][Full Text] [Related]
22. Milrinone therapy in catecholamine-dependent critically ill patients with heart failure. Siostrzonek P; Koreny M; Delle-Karth G; Haumer M; Koller-Strametz J; Heinz G Acta Anaesthesiol Scand; 2000 Apr; 44(4):403-9. PubMed ID: 10757572 [TBL] [Abstract][Full Text] [Related]
23. Improved mortality and haemodynamics with milrinone in cardiogenic shock due to acute decompensated heart failure. Rodenas-Alesina E; Luis Scolari F; Wang VN; Brahmbhatt DH; Mihajlovic V; Fung NL; Otsuki M; Billia F; Overgaard CB; Luk A ESC Heart Fail; 2023 Aug; 10(4):2577-2587. PubMed ID: 37322827 [TBL] [Abstract][Full Text] [Related]
24. Effects of intravenous home dobutamine in palliative end-stage heart failure on quality of life, heart failure hospitalization, and cost expenditure. Martens P; Vercammen J; Ceyssens W; Jacobs L; Luwel E; Van Aerde H; Potargent P; Renaers M; Dupont M; Mullens W ESC Heart Fail; 2018 Aug; 5(4):562-569. PubMed ID: 29341466 [TBL] [Abstract][Full Text] [Related]
25. Treatment of ischaemic left ventricular dysfunction with milrinone or dobutamine administered during coronary artery stenosis in the presence of beta blockade in pigs. Sidi A; Muehlschlegel JD; Kirby DS; Lobato EB Br J Anaesth; 2006 Dec; 97(6):799-807. PubMed ID: 17035336 [TBL] [Abstract][Full Text] [Related]
26. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide. Kurien S; Warfield KT; Wood CM; Miller WL Am J Cardiol; 2006 Dec; 98(12):1627-30. PubMed ID: 17145223 [TBL] [Abstract][Full Text] [Related]
27. Incidence and Predictors of Eosinophilic Myocardial Hypersensitivity in Patients Receiving Home Dobutamine. Dagan M; Lankaputhra M; Yeung T; Tee SL; Bader I; Easton K; Linton A; McLean C; Taylor A; Bergin P; Kaye DM; Leet A; Hare JL; Patel HC J Cardiovasc Pharmacol; 2022 Oct; 80(4):623-628. PubMed ID: 35853194 [TBL] [Abstract][Full Text] [Related]
28. Use of Outpatient Intravenous Calcitropes for Heart Failure in the United States. Gottlieb SS; Psotka MA; Desai N; Lindenfeld J; Russo P; Allen LA J Card Fail; 2021 Nov; 27(11):1276-1279. PubMed ID: 34265464 [TBL] [Abstract][Full Text] [Related]
29. Comparative efficacy of short-term intravenous infusions of milrinone and dobutamine in acute congestive heart failure following acute myocardial infarction. Milrinone-Dobutamine Study Group. Karlsberg RP; DeWood MA; DeMaria AN; Berk MR; Lasher KP Clin Cardiol; 1996 Jan; 19(1):21-30. PubMed ID: 8903534 [TBL] [Abstract][Full Text] [Related]
30. Comparison between mixed venous oxygen saturation and thermodilution cardiac output in monitoring patients with severe heart failure treated with milrinone and dobutamine. Nuñez S; Maisel A Am Heart J; 1998 Mar; 135(3):383-8. PubMed ID: 9580093 [TBL] [Abstract][Full Text] [Related]
31. Rotating inotrope therapy in a pediatric population with decompensated heart failure. Ryerson LM; Alexander PM; Butt WW; Shann FA; Penny DJ; Shekerdemian LS Pediatr Crit Care Med; 2011 Jan; 12(1):57-60. PubMed ID: 20453705 [TBL] [Abstract][Full Text] [Related]
32. Efficacy of milrinone and dobutamine in low cardiac output states: Systematic review and meta-analysis. Mathew R; Visintini SM; Ramirez FD; DiSanto P; Simard T; Labinaz M; Hibbert BM Clin Invest Med; 2019 Jun; 42(2):E26-32. PubMed ID: 31228965 [TBL] [Abstract][Full Text] [Related]
33. Comparative Effectiveness and Safety Between Milrinone or Dobutamine as Initial Inotrope Therapy in Cardiogenic Shock. Lewis TC; Aberle C; Altshuler D; Piper GL; Papadopoulos J J Cardiovasc Pharmacol Ther; 2019 Mar; 24(2):130-138. PubMed ID: 30175599 [TBL] [Abstract][Full Text] [Related]
34. Continuous Intravenous Inotropic Support for Advanced Heart Failure: Palliative Considerations. McPherson A; Nguyen C; Groninger H; Anderson KM; Henderson P; Rao A J Pain Palliat Care Pharmacother; 2022 Mar; 36(1):59-67. PubMed ID: 35319327 [TBL] [Abstract][Full Text] [Related]
35. Comparison of milrinone with dobutamine in patients undergoing cardiac surgery: a systematic review and meta-analysis. Alkadri J; Hu R; Jeffers MS; Ross J; McIsaac DI; McDonald B Can J Anaesth; 2023 Jul; 70(7):1272-1274. PubMed ID: 37160823 [No Abstract] [Full Text] [Related]
37. Current Targets and Future Directions of Positive Inotropes for Heart Failure. Fairuz S; Ang CW; Mraiche F; Goh JK Curr Med Chem; 2024; 31(42):6971-6991. PubMed ID: 37909442 [TBL] [Abstract][Full Text] [Related]
38. Symptomatic improvement in patients treated with intermittent infusion of inotropes: a double-blind placebo controled pilot study. López-Candales A; Vora T; Gibbons W; Carron C; Simmons P; Schwartz J J Med; 2002; 33(1-4):129-46. PubMed ID: 12939113 [TBL] [Abstract][Full Text] [Related]
39. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness. Colucci WS; Wright RF; Jaski BE; Fifer MA; Braunwald E Circulation; 1986 Mar; 73(3 Pt 2):III175-83. PubMed ID: 3510774 [TBL] [Abstract][Full Text] [Related]
40. The choice of perioperative inotropic support impacts the outcome of small infants undergoing complex cardiac surgery: an observational study. Willems A; Havaux R; Schmartz D; Fils JF; DE Pooter F; VAN DER Linden P Minerva Anestesiol; 2023 Sep; 89(9):753-761. PubMed ID: 37676176 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]